Navigation Links
CVS Caremark Reports Record Second Quarter Results
Date:8/6/2013

WOONSOCKET, R.I., Aug. 6, 2013 /PRNewswire/ -- CVS Caremark Corporation (NYSE: CVS) today announced operating results for the three months ended June 30, 2013.

(Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO)

Second Quarter Year-over-year Highlights:

  • Operating profit increased 15.2% to approximately $2.0 billion
  • Adjusted EPS increased 19.6% to $0.97; GAAP diluted EPS from continuing operations increased 20.8% to $0.91
  • Retail pharmacy same store prescription volumes increased 1.8%, or 5.0% on a 30-day equivalent basis
  • Retail pharmacy same store sales increased 0.8%; total same store sales increased 0.4%
  • Year-to-date Highlights:

  • Generated free cash flow of $1.7 billion
  • Cash flow from operations of $2.5 billion
  • 2013 Guidance:

  • Narrowed 2013 full-year Adjusted EPS range to $3.90 to $3.96 and GAAP diluted EPS from continuing operations range to $3.65 to $3.71
  • Provided third quarter Adjusted EPS guidance of $1.00 to $1.03 and GAAP diluted EPS from continuing operations guidance of $0.94 to $0.97
  • Expect full year free cash flow of $4.8 to $5.1 billion and cash flow from operations of $6.4 to $6.6 billion
  • RevenuesNet revenues for the three months ended June 30, 2013, increased 1.7%, or $534 million, compared to the three months ended June 30, 2012.

    Revenues in the Pharmacy Services Segment increased 2.0%, or $377 million, in the three months ended June 30, 2013. The growth was primarily driven by volume increases across all channels and drug cost inflation in our specialty pharmacy business, partially offset by the impact of new generic introductions. Pharmacy network claims processed during the three months ended June 30, 2013, increased 4.1% to 205.9 mil
    '/>"/>

    SOURCE CVS Caremark Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

    Related medicine technology :

    1. CVS Caremark Corporation to Hold First Quarter 2012 Conference Call
    2. CVS Caremark Reports Record First Quarter Results
    3. CVS Caremark Sponsored Research Finds FDA Drug Warnings Can Have Immediate Negative Impact on Medication Adherence, Even if Not Related to Safety
    4. CVS Caremark Research Identifies Positive Link Between Medication Adherence and Employee Productivity
    5. CVS Caremark Charitable Trust Partners with National Association of Community Health Centers to Create Innovative Grant Program Focused on Managing Chronic Disease
    6. CVS Caremark To Present At Goldman Sachs 2012 Global Retailing Conference
    7. CVS Caremark to Present at Morgan Stanley Global Healthcare Conference
    8. CVS Caremark Corporation Announces New Share Repurchase Authorization for up to $6 Billion of Common Stock
    9. CVS Caremark Donates More Than $100,000 to Hurricane Sandy Relief Efforts
    10. CVS Caremark To Present At Lazard Capital Markets 9th Annual Healthcare Conference
    11. CVS Caremark Reports Third Quarter Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/1/2015)... The global Bioinformatics ... sectors, products & services and application. And the rising ... increasing demand of advanced drugs for the diagnosis ... growth for bioinformatics market. The implementation of information ... as bioinformatics. Decreasing cost of DNA sequencing, continuous ...
    (Date:9/1/2015)... Research and Markets ( http://www.researchandmarkets.com/research/r8v22b/regulatory ) has announced the ... (London, UK - September 24-25, 2015)" conference to ... provides an introduction to Pharmaceutical Regulatory Affairs and the ... for those working in a support staff role. ... regulatory procedures required to register products in ...
    (Date:9/1/2015)... , September 1, 2015 - ... GARFIELD-AF R egistry data presented at ... on the evolution of manag ... -   The first-ever two-year outcomes from ... ESC Congress 2015 expose that all-cause death was the most frequent major event ...
    Breaking Medicine Technology:Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 2Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 3Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 4Regulatory Affairs for Support Staff Seminar (London, UK - September 24-25, 2015) 2Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 2Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 3Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 4Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 5Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 6Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 7Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 8Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 9
    (Date:9/1/2015)... ... September 01, 2015 , ... ... Blue Cross and Blue Shield of Minnesota (Blue Cross) has announced Doctor On ... Based in San Francisco, Doctor On Demand provides immediate access to Board Certified ...
    (Date:9/1/2015)... ... 2015 , ... Virginia entrepreneur Marcella Ellis, CEO and founder ... firm’s success in the hair care and distribution industry through her combination of ... be providing “Look and learn” live demonstrations, as well as promoting her new ...
    (Date:9/1/2015)... ... September 01, 2015 , ... ... Screeners (NAPBS®) has announced that Edge Information Management has been granted ... Background Screening Credentialing Council (BSCC). , “Achieving and maintaining this accreditation ...
    (Date:9/1/2015)... ... ... With former IBMers among its founding members, Inmar has known the value ... years ago. A pilot program begun by the company in 2014 has proved popular ... on pursuing careers in these fields. The program is now open to area middle ...
    (Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... Royal River ... new study that followed men and women for 19 years and found that, among ... did not take multivitamins. , The report is part of the September 2015 issue ...
    Breaking Medicine News(10 mins):Health News:Blue Cross and Blue Shield of Minnesota names Doctor On Demand as preferred telehealth destination 2Health News:Blue Cross and Blue Shield of Minnesota names Doctor On Demand as preferred telehealth destination 3Health News:Beauty Entrepreneur creates hair extension smart machine and mobile app inspired by UBER technology 2Health News:Edge Information Management Granted Continued NAPBS Accreditation 2Health News:Edge Information Management Granted Continued NAPBS Accreditation 3Health News:Inmar Announces Program to Fuel Student Passion for STEM – with an Unconventional Twist 2Health News:New Study Finds Multivitamins Extend Life After Stroke, Retailer Reports 2
    ... SOA integration, and Complex-Event Processing (CEP) Technologies Unified ... 30 First Choice Professionals, LLC., today announced ... TIBX ), to provide healthcare organizations with ... solution. FCP,s renowned healthcare integration group will combine ...
    ... Inc. (NYSE: IMA ), a global leader in ... through the merger of rapid diagnostics and health management, announced ... C. DIFF QUIK CHEK COMPLETE (TM) rapid test as ... difficile associated disease (CDAD). This follows TECHLAB(R), Inc.,s recent ...
    ... Sheets: IMMB) has completed a reverse merger with a ... a 100 to 1 reverse split of stock. ... the total number of issued and outstanding shares to ... IMMB.Immunotech Laboratories, Inc. has indefinite licensing rights of the ...
    ... at a rate not seen in more than twenty years, creating ... insurance for small business is being called a top priority at ... and (NFIB) and America,s Health Insurance Plans (AHIP). , ... ...
    ... MONDAY, March 30 (HealthDay News) -- Babies who gain weight ... more prone to obesity as toddlers, Harvard researchers report. , ... much younger," said study author Dr. Elsie M. Taveras. "Even ... start guiding parents about how to prevent rapid weight gain ...
    ... Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) today ... Annual Meeting of Stockholders. Over the past several months, ... independent directors, engaged in a rigorous process to identify ... the Board strongly believes will best serve the interests ...
    Cached Medicine News:Health News:First Choice Professionals and TIBCO Announce Strategic Partnership to Advance Healthcare Integration 2Health News:Inverness Medical Innovations Launches New FDA Cleared C. DIFF QUIK CHEK COMPLETE(TM) Rapid Test 2Health News:Inverness Medical Innovations Launches New FDA Cleared C. DIFF QUIK CHEK COMPLETE(TM) Rapid Test 3Health News:Inverness Medical Innovations Launches New FDA Cleared C. DIFF QUIK CHEK COMPLETE(TM) Rapid Test 4Health News:Immunotech Completes Merger Acquisition 2Health News:BestHealthcareRates.com Reports Highest Cancellation Rate of Employee Benefit Plans in More Than Two Decades 2Health News:BestHealthcareRates.com Reports Highest Cancellation Rate of Employee Benefit Plans in More Than Two Decades 3Health News:BestHealthcareRates.com Reports Highest Cancellation Rate of Employee Benefit Plans in More Than Two Decades 4Health News:Rapid Infant Weight Gain Linked to Childhood Obesity 2Health News:Amylin Pharmaceuticals Announces Slate of Directors for Annual Meeting of Stockholders 2Health News:Amylin Pharmaceuticals Announces Slate of Directors for Annual Meeting of Stockholders 3Health News:Amylin Pharmaceuticals Announces Slate of Directors for Annual Meeting of Stockholders 4
    Used to negotiate tortuous vessels....
    BiodivYsio stent with biocompatible coating (phosphorylcholine)...
    ... The CYPHER Sirolimus-eluting Coronary Stent ... drug, called "sirolimus", a controlled-release ... delivery platform. Upon placement, sirolimus ... and impedes the process of ...
    PT wires combine the enhanced durability of a linear elastic nitinol distal core and a highly resilient polymer tip. This provides excellent access in difficult cases involving severe tortuosity, tig...
    Medicine Products: